Yan Qu is a Senior Principal Scientist at Rinat, which is part of the Oncology Research and Development Group. Since joining Pfizer in 2013, she has been supporting avelumab preclinical research work through collaboration with the Pfizer global development team. More recently, Dr. Qu has been exploring therapeutic strategies targeting myeloid populations and designing the next generation antiCD40 Ab and cytokine fusion protein.
oncolgy